Xcout Intel
Salspera, Inc.
Salspera, Inc. is a biopharmaceutical company that develops genetically engineered microbial immunotherapies designed to treat solid tumors. Its lead candidate, Saltikva, uses synthetic biology to target tumors and activate the body's natural killer cells while aiming to minimize toxicity and enhance the effects of traditional chemotherapy.
Subscribe to see Salspera, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Salspera, Inc. at a glance
Salspera, Inc. is a biotechnology company headquartered in United States. Xcout tracks 2 named people at Salspera, Inc., including Eddie Moradian (Chief Executive Officer).
Salspera, Inc. leadership
- Eddie MoradianChief Executive Officer
- Daniel SaltzmanChief Medical Officer
Recent Salspera, Inc. news
Get Salspera, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Salspera, Inc. in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 3 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access